Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$338.91 - $506.01 $1.22 Million - $1.82 Million
3,600 New
3,600 $1.37 Million
Q2 2020

Aug 14, 2020

SELL
$127.44 - $232.72 $569,784 - $1.04 Million
-4,471 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$108.83 - $165.23 $174,128 - $264,368
-1,600 Reduced 26.35%
4,471 $589,000
Q4 2019

Feb 14, 2020

SELL
$106.59 - $164.21 $1.69 Million - $2.61 Million
-15,898 Reduced 72.37%
6,071 $975,000
Q3 2019

Nov 14, 2019

SELL
$113.31 - $150.51 $1.11 Million - $1.47 Million
-9,781 Reduced 30.81%
21,969 $2.5 Million
Q2 2019

Aug 14, 2019

SELL
$115.0 - $141.58 $448,500 - $552,162
-3,900 Reduced 10.94%
31,750 $4.5 Million
Q1 2019

May 15, 2019

SELL
$98.85 - $134.59 $2.24 Million - $3.05 Million
-22,650 Reduced 38.85%
35,650 $4.45 Million
Q4 2018

Feb 14, 2019

SELL
$63.81 - $109.82 $382,860 - $658,920
-6,000 Reduced 9.33%
58,300 $5.6 Million
Q3 2018

Nov 14, 2018

BUY
$75.5 - $96.63 $2.9 Million - $3.71 Million
38,351 Added 147.79%
64,300 $4.88 Million
Q2 2018

Aug 13, 2018

SELL
$74.84 - $100.16 $2.41 Million - $3.22 Million
-32,181 Reduced 55.36%
25,949 $2.15 Million
Q1 2018

May 15, 2018

SELL
$56.95 - $85.19 $2.12 Million - $3.17 Million
-37,266 Reduced 39.06%
58,130 $4.68 Million
Q4 2017

Feb 14, 2018

BUY
$22.57 - $63.56 $1.25 Million - $3.52 Million
55,396 Added 138.49%
95,396 $6.02 Million
Q3 2017

Nov 14, 2017

BUY
$19.81 - $22.61 $792,400 - $904,400
40,000
40,000 $904,000

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.